Search

Your search keyword '"Masuzaki, Hideaki"' showing total 829 results
Start Over Author "Masuzaki, Hideaki"
829 results on '"Masuzaki, Hideaki"'

1. Retrospective details of false-positive and false-negative results in non-invasive prenatal testing for fetal trisomies 21, 18 and 13

Author

Suzumori, Nobuhiro, Sekizawa, Akihiko, Takeda, Eri, Samura, Osamu, Sasaki, Aiko, Akaishi, Rina, Wada, Seiji, Hamanoue, Haruka, Hirahara, Fumiki, Sawai, Hideaki, Nakamura, Hiroaki, Yamada, Takahiro, Miura, Kiyonori, Masuzaki, Hideaki, Nakayama, Setsuko, Kamei, Yoshimasa, Namba, Akira, Murotsuki, Jun, Yamaguchi, Masayuki, Tairaku, Shinya, Maeda, Kazuhisa, Kaji, Takashi, Okamoto, Yoko, Endo, Masayuki, Ogawa, Masaki, Kasai, Yasuyo, Ichizuka, Kiyotake, Yamada, Naoki, Ida, Akinori, Miharu, Norio, Kawaguchi, Satoshi, Hasuo, Yasuyuki, Okazaki, Tetsuya, Ichikawa, Mayuko, Izumi, Shunichiro, Kuno, Naohiko, Yotsumoto, Junko, Nishiyama, Miyuki, Shirato, Nahoko, Hirose, Tatsuko, and Sago, Haruhiko

Published
2021
Full Text
View/download PDF

6. Fetal cell-free DNA fraction in maternal plasma for the prediction of hypertensive disorders of pregnancy

Author

Suzumori, Nobuhiro, Sekizawa, Akihiko, Ebara, Takeshi, Samura, Osamu, Sasaki, Aiko, Akaishi, Rina, Wada, Seiji, Hamanoue, Haruka, Hirahara, Fumiki, Izumi, Haruna, Sawai, Hideaki, Nakamura, Hiroaki, Yamada, Takahiro, Miura, Kiyonori, Masuzaki, Hideaki, Yamashita, Takahiro, Okai, Takashi, Kamei, Yoshimasa, Namba, Akira, Murotsuki, Jun, Tanemoto, Tomohiro, Fukushima, Akimune, Haino, Kazufumi, Tairaku, Shinya, Matsubara, Keiichi, Maeda, Kazutoshi, Kaji, Takashi, Ogawa, Masanobu, Osada, Hisao, Nishizawa, Haruki, Okamoto, Yoko, Kanagawa, Takeshi, Kakigano, Aiko, Kitagawa, Michihiro, Ogawa, Masaki, Izumi, Shunichiro, Katagiri, Yukiko, Takeshita, Naoki, Kasai, Yasuyo, Naruse, Katsuhiko, Neki, Reiko, Masuyama, Hisashi, Hyodo, Maki, Kawano, Yukie, Ohba, Takashi, Ichizuka, Kiyotake, Nagamatsu, Takeshi, Watanabe, Atsushi, Shirato, Nahoko, Yotsumoto, Junko, Nishiyama, Miyuki, Hirose, Tatsuko, and Sago, Haruhiko

Published
2018
Full Text
View/download PDF

8. Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan

Author

Okuma, Kazu, Kuramitsu, Madoka, Niwa, Toshihiro, Taniguchi, Tomokuni, Masaki, Yumiko, Ueda, Gohzoh, Matsumoto, Chieko, Sobata, Rieko, Sagara, Yasuko, Nakamura, Hitomi, Satake, Masahiro, Miura, Kiyonori, Fuchi, Naoki, Masuzaki, Hideaki, Okayama, Akihiko, Umeki, Kazumi, Yamano, Yoshihisa, Sato, Tomoo, Iwanaga, Masako, Uchimaru, Kaoru, Nakashima, Makoto, Utsunomiya, Atae, Kubota, Ryuji, Ishitsuka, Kenji, Hasegawa, Hiroo, Sasaki, Daisuke, Koh, Ki-Ryang, Taki, Mai, Nosaka, Kisato, Ogata, Masao, Naruse, Isao, Kaneko, Noriaki, Okajima, Sara, Tezuka, Kenta, Ikebe, Emi, Matsuoka, Sahoko, Itabashi, Kazuo, Saito, Shigeru, Watanabe, Toshiki, and Hamaguchi, Isao

Published
2020
Full Text
View/download PDF

9. Data from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

10. Supplementary Table 3 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

11. Supplementary Table 5 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

12. Supplementary Table 2 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

13. Supplementary Table 6 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

14. Supplementary Figure 8 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

15. Supplementary Table 1 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

16. Supplementary Figure 2 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

17. Supplementary Figure 7 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

18. Supplementary Table 4 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

19. Supplementary Figure 3 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

20. Supplementary Figure 4 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figure 6 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

22. Supplementary Figure 5 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

23. Supplementary Materials and Methods from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

24. Supplementary Figure 1 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

34. 長崎大学医学部

Author

Matsumoto, Takehiro, Taura, Naota, Kawasaki, Koji, Masuzaki, Hideaki, and Honda, Masayuki

Subjects
Health Information Exchange, EHR, hospital management, HIE
Abstract

Recently Health Information Exchange (HIE) has been gradually spreading in Japan. In this study, the effect against the hospital management of the HIE named the Ajisai-net of Nagasaki prefecture in Japan was evaluated through investigations of both the number of the first visit patients and hospitalized patients. The first visit is classified into three types. The first type is the reserved first visit bringing the introduction letters, 2nd type is the non-reserved first visit bringing the introduction letters and 3rd type is non-reserved first visit not bringing the introduction letters. The total number of hospitalized patients was 12,237/32,398 (37.8%) on the first type, 8,764/ 24,549 (35.7%) on the second type and 1,277/7,167 (17.8%) on the third type, and there were significantly differences among 3 types. (p, Acta medica Nagasakiensia, 64(2), pp.39-44; 2020

Published
2020

43. 長崎大学医学部

Author

Yamasaki, Makiko, Abe, Shuhei, Miura, Kiyonori, and Masuzaki, Hideaki

Subjects
HPV, participation rate, cervical cancer screening, carcinoma in situ, self-sampling, non-attenders
Abstract

Aim: Self-sampling devices for oncogenic human papillomavirus (HPV) testing may be useful for improving participation in cervical cancer screening. The aim of this study was to investigate the effects of HPV self-sampling devices for non-attenders, who have not participated in regular cervical cancer screening. Methods: To determine whether HPV self-sampling devices improve participation in cervical cancer screening on a remote island, non-attenders aged 20?49 years were included in this study. Participation was defined as returning a self-sampling device and/or participating in a conventional cytology-based cervical cancer screening. From April 2014 to May 2015, written informed consent for participation in this study was obtained from 249 of 2,986 non-attenders in the Goto Islands and randomly assigned to the “re-call” group (n=124) or the self-sampling group (n=125). Results: The participation (by returning the HPV self-sampling device and/or attending a cervical cancer screening) rate was 12.1% (n = 15) in the “re-call” group and 76.0% (n = 95) in the self-sampling group. Only 50% of HPV-positive women (n=5) underwent cytological testing, and abnormal cytological findings were detected in two cases. For these two patients with abnormal cytology, carcinoma in situ was detected and treated. Conclusions: Offering HPV self-sampling devices may improve participation in cervical cancer screening on remote islands in Japan., Acta medica Nagasakiensia, 62(2), pp.55-61; 2019

Published
2019

48. Predicting time to ovarian carcinoma recurrence using protein markers

Author

Yang, Ji-Yeon, Yoshihara, Kosuke, Tanaka, Kenichi, Hatae, Masayuki, Masuzaki, Hideaki, Itamochi, Hiroaki, Network, Research, Takano, Masashi, Ushijima, Kimio, Tanyi, Janos, Coukos, George, Lu, Yiling, Mills, Gordon, and Verhaak, Roel

Subjects
Diseases -- Relapse, Ovarian cancer -- Development and progression -- Patient outcomes, Biological markers -- Research, Health care industry
Abstract

Patients with ovarian cancer are at high risk of tumor recurrence. Prediction of therapy outcome may provide therapeutic avenues to improve patient outcomes. Using reverse-phase protein arrays, we generated ovarian carcinoma protein expression profiles on 412 cases from TCGA and constructed a PRotein-driven index of OVARian cancer (PROVAR). PROVAR significantly discriminated an independent cohort of 226 high-grade serous ovarian carcinomas into groups of high risk and low risk of tumor recurrence as well as short-term and long-term survivors. Comparison with gene expression-based outcome classification models showed a significantly improved capacity of the protein-based PROVAR to predict tumor progression. Identification of protein markers linked to disease recurrence may yield insights into tumor biology. When combined with features known to be associated with outcome, such as BRCA mutation, PROVAR may provide clinically useful predictions of time to tumor recurrence., Introduction Ovarian cancer is the deadliest gynecologic cancer in the United States, with 22,240 new cases and 14,030 deaths in 2013 (1). High-grade serous cancer is the most common ovarian [...]

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results